Ilhem Dallali

Dr. Ilhem Dallali

VIB-KU Leuven Center for Brain & Disease Research, Leuven, Belgium
orcid
Postdoctoral researcher

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2024 in ACS Omega
Verified
Journal Article
Open access
IBIman Baramaki
Iman Baramaki
Mehlika Dilek AltıntopMehlika Dilek Altıntop
Mehlika Dilek Altıntop
RARana Arslan
Rana Arslan
FAFeyza Alyu Altınok
Feyza Alyu Altınok
Ahmet ÖzdemirAhmet Özdemir
Ahmet Özdemir
NTNurcan Bektaş Türkmen
Nurcan Bektaş Türkmen
Indole-chalcone hybrids have burst into prominence as potent weapons in the battle against pain and inflammation due to their unique features, allowing these ligands to form pivotal interactions with biological targets. In this context, the base-catalyzed Claisen–Schmidt condensation of 3′,4′-(methylenedioxy)acetophenone with heteroaromatic aldehydes carrying an indole scaffold yielded new chalcones (1–7). The central and peripheral antinociceptive activities of all chalcones (compounds 1–7) at the dose of 10 mg/kg (i.p.) were evaluated by hot plate (supraspinal response), tail immersion (spinal response), and acetic acid-induced writhing tests in mice. The anti-inflammatory activities of compounds 1–7 were also investigated by means of a carrageenan-induced mouse paw edema model. The results revealed that compounds 1–7 extended the latency of response to thermal stimulus significantly in a hot-plate test similar to dipyrone (300 mg/kg; i.p.), the positive control drug. However, only compounds 2–7 were found to be significantly effective in the tail-immersion test. Compounds 1–7 also significantly showed analgesic effect by reducing the number of writhes and anti-inflammatory activity by inhibiting edema formation at different time intervals and levels. 1-(1,3-Benzodioxol-5-yl)-3-(1-methyl-1H-indol-2-yl)prop-2-en-1-one (4) drew attention by providing the highest efficacy results in both acute analgesia and inflammation models. Based on the in silico data acquired from the QikProp module, compound 4 was predicted to possess favorable oral bioavailability and drug-like properties. Taken together, it can be concluded that chalcones (1–7), especially compound 4, are outstanding candidates for further research to investigate their potential use in the management of pain and inflammation.

8 April 2024 in Journal of Pharmacy and Pharmacology
Verified
Journal Article
Closed access
PDF file
EKElif Karabacak
Elif Karabacak
HEHazal Eken
Hazal Eken
Ilhem DallaliIlhem Dallali
Ilhem Dallali
RARana Arslan
Rana Arslan
We purposed to explore the consequences of the use quercetin and fisetin alone and in combination with pregabalin and gabapentin, which are used in the management of neuropathic pain, and on neuropathic pain in general. The anti-allodynic effect of various doses (5, 10, and 20 mg/kg) of quercetin and fisetin, both singly and in combination with pregabalin and gabapentin, was evaluated by developing a neuropathic pain model induced by chronic constrictive nerve damage in rats. The effectiveness of these flavonoids was investigated by combining them with gabapentin (50 mg/kg) and pregabalin (15 mg/kg), choosing the effectual dose of 10 mg/kg and the dose of 5 mg/kg, which did not show significant antiallodynic effects. In groups combined with gabapentin and pregabalin, it was determined that they showed a significant antiallodynic effect compared with 50 mg/kg gabapentin and 15 mg/kg pregabalin. In conclusion, in our combination studies, it was observed that the effectiveness of gabapentin and pregabalin, was increased and the duration of effect was prolonged when used with lower doses of flavonoids. Based on these findings; it is possible to say that quercetin and fisetin are potential agents that can be used alone or in combination with other effective treatments to alleviate neuropathic pain.

12 November 2024 in Neuroscience Letters
Verified
Journal Article
Closed access
FAFeyza Alyu
Feyza Alyu
Ilhem DallaliIlhem Dallali
Ilhem Dallali
ABAbderaouf Boubekka
Abderaouf Boubekka
Ahmed HasanAhmed Hasan
Ahmed Hasan
YOYusuf Ozturk
Yusuf Ozturk

20 September 2024 in Neuroscience Letters
Verified
Journal Article
Closed access
AKAhmet Alper Karakus
Ahmet Alper Karakus
Ilhem DallaliIlhem Dallali
Ilhem Dallali
RARana Arslan
Rana Arslan
HEHazal Eken
Hazal Eken
Ahmed HasanAhmed Hasan
Ahmed Hasan
NBNurcan Bektas
Nurcan Bektas

15 June 2026 in Journal of the American Society of Nephrology
Verified
Journal Article
Open access
OAOyindamola Christiana Adebayo
Oyindamola Christiana Adebayo
Ilhem DallaliIlhem Dallali
Ilhem Dallali
SKSara Kerselaers
Sara Kerselaers
SGSergio Gimeno-Rocafort
Sergio Gimeno-Rocafort
SASandra Van Aerschot
Sandra Van Aerschot
VLVeerle Labarque
Veerle Labarque
Key Points: Apolipoprotein L1 variants were transported to the plasma membrane via actin filaments, where they exhibited distinct dynamics. Apolipoprotein L1 was functionally expressed at the plasma membrane and formed a voltage-dependent non-selective cation-permeable pore. Influx of calcium from the extracellular medium was the primary origin of the increased cytosolic calcium crucial for Apolipoprotein L1 cytotoxicity. Background: The mechanisms by which apolipoprotein L1 ( APOL1 ) risk variants, G1 and G2, induce kidney disease in individuals of African ancestry remain contentious. Methods: In this study, we utilized a heterologous expression system of HEK-293 cells and human podocytes to investigate APOL1-mediated cytotoxicity using genetic, electrophysiological, and microscopy-based approaches. Results: APOL1 variants showed dynamic transport in vesicle-like structures toward the plasma membrane via actin filaments. At the plasma membrane, the non-risk APOL1 G0 and risk variants formed non-selective cation-permeable pores for Na + and Ca 2+ , exhibiting functional activity under basal conditions. Extracellular Ca 2+ was identified as the primary source of Ca 2+ influx through APOL1, leading to cytotoxicity. APOL1 risk variants exhibited increased basal channel activity compared to non-risk APOL1 G0, resulting in haplotype-dependent cytotoxicity. Furthermore, we observed that both the M1 (N264K) variant and APOL1 inhibitor, Inaxaplin, exerted protective effects on cell viability by blocking the APOL1-dependent intracellular Ca 2+ influx. Conclusions: This study demonstrated APOL1 to be a membrane protein involved in the influx of Ca 2+ from the extracellular medium. Increased activity of APOL1 led to markedly increased cytotoxicity, which supports the gain-of-function theory. This effect was prevented by the presence of N264K variant or treatment with the APOL1 inhibitor, Inaxaplin.

14 January 2026 in Communications Chemistry
Verified
Journal Article
Open access
PDF file
KHKatharina Held
Katharina Held
EHEvelien Van Hoeymissen
Evelien Van Hoeymissen
Ilhem DallaliIlhem Dallali
Ilhem Dallali
EPEleonora Persoons
Eleonora Persoons
BBBahar Bazeli
Bahar Bazeli
JVJoris Vriens
Joris Vriens
Transient Receptor Potential Melastatin 3 (TRPM3) is a non-selective, Ca2+-permeable ion channel that plays a pivotal role in peripheral thermosensation and nociception. Moreover, gain-of-function variants in TRPM3 underlie a spectrum of neurodevelopmental and epileptic disorders in humans, indicating an important role of TRPM3 in the central nervous system. Oxidative stress contributes to various neurological disorders of both the central and peripheral nervous system, but it is unknown whether TRPM3 activity is altered by the cellular redox state. Here, we report a direct, bidirectional modification of TRPM3 channel activity by oxidizing and reducing agents. Our data demonstrate a profound effect of the redox state on the channel properties of TRPM3, including a robust shift in the response profile to pharmacology and temperature sensitivity. In addition, we identified two cysteine residues in the extracellular pore loop of TRPM3 that underlie the redox-control of the channel, due to the reversible formation of intra-subunit cysteine bridges. Taken together, these observations raise the hypothesis that TRPM3 could be modulated through an alternative mechanism, potentially affecting pathways involved in pain and neurological function.